Johnson & Johnson said on Friday it resumed the limited market release of its Varipulse heart device in the United States ...
18h
FY 2025 revenue forecast has been revised to ¥997.5 billion, considering progress and challenges in China. Adjusted operating profit is projected at ¥174.5 billion, with an adjusted operating margin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback